Treatment of Recurrent Hepatitis C in Liver Transplant Recipients With Extended Duration of Pegylated Interferon and Ribavirin

被引:0
|
作者
Arrigo, Richard
Samanta, Arun
Griffith, Shanthini
Parekh, Ravish M.
Korogodsky, Maria
Rao, Kiran V.
Fisher, Adrian
Wilson, Dorian
Klein, Kenneth M.
Koneru, Baburao
机构
关键词
D O I
暂无
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
引用
收藏
页码:S459 / S459
页数:1
相关论文
共 50 条
  • [1] Pegylated interferon therapy with/without ribavirin in liver transplant recipients with recurrent hepatitis C infection
    Levitsky, J
    Cohen, SM
    Dasgupta, KA
    Faust, TW
    Te, HS
    [J]. HEPATOLOGY, 2002, 36 (04) : 182A - 182A
  • [2] Pilot study of treatment with pegylated interferon and ribavirin in liver transplant recipients with hepatitis C infection
    Roche, B
    Roque-Afonso, AM
    Sebagh, M
    Feray, C
    Guettier, C
    Dussaix, E
    Castaing, D
    Samuel, D
    [J]. JOURNAL OF HEPATOLOGY, 2003, 38 : 48 - 49
  • [3] Pilot study of treatment with pegylated interferon and ribavirin in liver transplant recipients with hepatitis C infection
    Roche, B
    Roque-Afonso, AM
    Sebagh, M
    Feray, C
    Guettier, C
    Dussaix, E
    Castaing, D
    Samuel, D
    [J]. LIVER TRANSPLANTATION, 2003, 9 (06) : C6 - C6
  • [4] Outcome of Treatment With Pegylated Interferon and Ribavirin in Heart Transplant Recipients With Chronic Hepatitis C
    Durante-Mangoni, E.
    Ragone, E.
    Pinto, D.
    Iossa, D.
    Covino, F. E.
    Maiello, C.
    Utili, R.
    [J]. TRANSPLANTATION PROCEEDINGS, 2011, 43 (01) : 299 - 303
  • [5] Treatment of established recurrent hepatitis C in liver-transplant recipients with pegylated interferon-alfa-2b and ribavirin therapy
    Neff, GW
    Montalbano, M
    O'Brien, CB
    Nishida, S
    Safdar, K
    Bejarano, PA
    Khaled, AS
    Ruiz, P
    Slapak-Green, G
    Lee, M
    Nery, J
    De Medina, M
    Tzakis, A
    Schiff, ER
    [J]. TRANSPLANTATION, 2004, 78 (09) : 1303 - 1307
  • [6] Impact of pegylated interferon alfa-2b and ribavirin on depression in liver transplant recipients with recurrent hepatitis C
    Challis, M
    Rogge, J
    Weaver, L
    Mukherjee, S
    [J]. GASTROENTEROLOGY, 2004, 126 (04) : A699 - A699
  • [7] Preemptive therapy with combination pegylated interferon and ribavirin in liver transplant recipients with hepatitis C virus
    Neff, GW
    O'Brien, CB
    Safdar, K
    Ruiz, P
    Bejarano, P
    Montalbano, M
    Schiff, ER
    [J]. GASTROENTEROLOGY, 2004, 126 (04) : A695 - A695
  • [8] IMPACT OF PEGYLATED INTERFERON AND RIBAVIRIN TREATMENT ON GRAFT SURVIVAL IN LIVER TRANSPLANT PATIENTS WITH RECURRENT HEPATITIS C INFECTION
    Veldt, B. J.
    Poterucha, J. J.
    Watt, K. D. S.
    Weisner, R. H.
    Hay, J. E.
    Kremers, W. K.
    Rosen, C. B.
    Heimbach, J. K.
    Charlton, M. R.
    [J]. LIVER TRANSPLANTATION, 2008, 14 (07) : S183 - S183
  • [9] Interferon alfa and ribavirin for orthotopic liver transplant recipients with recurrent hepatitis C.
    Firpi, RJ
    Abdelmalek, MF
    Lauwers, GY
    Nelson, DR
    [J]. GASTROENTEROLOGY, 2000, 118 (04) : A1018 - A1018
  • [10] Pegylated-interferon for recurrent hepatitis C in liver transplant recipients with renal failure
    Mukherjee, S
    Gilroy, RK
    McCashland, TM
    Schafer, DF
    Zetterman, RK
    Sorrell, MF
    [J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 2002, 97 (09): : S95 - S95